Skip to main content

Cigna Group

For the period ended Mar 31, 2024. Filed May 2, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 2, 2024

CI$303.13+2.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Cash Flows

The Cigna Group

Consolidated Statements of Cash Flows

Unaudited
Three Months Ended March 31,
(In millions)20242023
Cash Flows from Operating Activities
Net (loss) income$(212)$1,306
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization741749
Realized investment losses, net1,83656
Deferred income tax benefit(102)(108)
Loss on sale of businesses19—
Net changes in assets and liabilities, net of non-operating effects:
Accounts receivable, net(2,687)(479)
Inventories1,015566
Reinsurance recoverable and Other assets6872
Insurance liabilities5321,533
Pharmacy and other service costs payable4,637539
Accounts payable and Accrued expenses and other liabilities(1,068)690
Other, net61104
NET CASH PROVIDED BY OPERATING ACTIVITIES4,8405,028
Cash Flows from Investing Activities
Proceeds from investments sold:
Debt securities and equity securities268196
Investment maturities and repayments:
Debt securities and equity securities179257
Commercial mortgage loans44
Other sales, maturities and repayments (primarily short-term and other long-term investments)272160
Investments purchased or originated:
Debt securities and equity securities(180)(2,794)
Commercial mortgage loans(32)—
Other (primarily short-term and other long-term investments)(594)(377)
Property and equipment purchases, net(300)(408)
Divestitures, net of cash sold—22
Other, net(112)(43)
NET CASH USED IN INVESTING ACTIVITIES(495)(2,983)
Cash Flows from Financing Activities
Deposits and interest credited to contractholder deposit funds4345
Withdrawals and benefit payments from contractholder deposit funds(65)(48)
Net change in short-term debt(364)(9)
Repayment of long-term debt(2,210)(80)
Net proceeds on issuance of long-term debt4,4621,491
Repurchase of common stock(4,022)(962)
Issuance of common stock18130
Common stock dividend paid(401)(368)
Other, net(153)(136)
NET CASH USED IN FINANCING ACTIVITIES(2,529)(37)
Effect of foreign currency rate changes on cash, cash equivalents and restricted cash(9)5
Net increase in cash, cash equivalents and restricted cash1,8072,013
Cash, cash equivalents and restricted cash January 1,8,3375,976
Cash, cash equivalents and restricted cash, March 31, (1)10,1447,989
Cash and cash equivalents reclassified to assets of businesses held for sale(1,660)—
Cash, cash equivalents and restricted cash March 31, per Consolidated Balance Sheets (1)$8,484$7,989
Supplemental Disclosure of Cash Information:
Income taxes paid, net of refunds$110$77
Interest paid$336$322

(1)Restricted cash and cash equivalents were reported in other long-term investments.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.